Clinical Trials Browser

Phase 3 × Papillomavirus Infections × Diphtheria-Tetanus-acellular Pertussis Vaccines × Clear all

NCT01627561 2020-04-10

Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old

Phase 3 Completed

148 enrolled 28 charts

Papillomavirus Infections